BAYN

Bayer AG

  • Germany
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
32.6
FY22:
37.8
FY23:
37.6
FY24:
34.4
FY25:
32.9
(positive)
Change from FY21 to FY25
billions EUR
FY21:
87.7
FY22:
87.1
FY23:
78.7
FY24:
76.4
FY25:
71.6
Total assets
Change from FY21 to FY25
billions EUR
FY21:
120
FY22:
125
FY23:
116
FY24:
111
FY25:
105

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
29.4
FY22:
35.1
FY23:
29.5
FY24:
29.0
FY25:
32.6
(negative)
Change from FY21 to FY25
billions EUR
FY21:
57.7
FY22:
50.9
FY23:
53.7
FY24:
49.9
FY25:
45.9
(positive)
Change from FY21 to FY25
billions EUR
FY21:
33.2
FY22:
38.9
FY23:
33.1
FY24:
32.0
FY25:
26.1
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
120
FY22:
125
FY23:
116
FY24:
111
FY25:
105

All amounts in billions EUR Data source:Twelve Data